Fragile X syndrome: an update on developing treatment modalities
- PMID: 22860169
- PMCID: PMC3369755
- DOI: 10.1021/cn200019z
Fragile X syndrome: an update on developing treatment modalities
Abstract
Intellectual disability (ID; mental retardation) is considered an immutable condition. Current medical practices are aimed at relieving symptoms and not at altering the underlying cognitive deficits. Scientific advancements from the past decade have led to the exciting possibility that ID may now be treatable. Moreover, pharmaceutical therapies targeting the most common form of inherited ID, Fragile X syndrome (FXS), may become the new benchmark for central nervous system (CNS) drug discovery: seeking cures for neurodevelopmental disorders.
Keywords: Fragile X syndrome; fragile X mental retardation gene; fragile X mental retardation protein; metabotropic glutamate receptor 5; γ-aminobutyric acid.
Figures
Similar articles
-
Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics.ACS Chem Neurosci. 2011 Aug 17;2(8):433-49. doi: 10.1021/cn200043e. Epub 2011 Jun 14. ACS Chem Neurosci. 2011. PMID: 22860170 Free PMC article. Review.
-
Fragile X syndrome and targeted treatment trials.Results Probl Cell Differ. 2012;54:297-335. doi: 10.1007/978-3-642-21649-7_17. Results Probl Cell Differ. 2012. PMID: 22009360 Free PMC article. Review.
-
Potential therapeutic interventions for fragile X syndrome.Trends Mol Med. 2010 Nov;16(11):516-27. doi: 10.1016/j.molmed.2010.08.005. Epub 2010 Sep 21. Trends Mol Med. 2010. PMID: 20864408 Free PMC article. Review.
-
Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.Neuropsychopharmacology. 2012 Jan;37(1):178-95. doi: 10.1038/npp.2011.137. Epub 2011 Jul 27. Neuropsychopharmacology. 2012. PMID: 21796106 Free PMC article. Review.
-
[From intellectual disability to new treatment modalities of fragile X syndrome].Ugeskr Laeger. 2014 Feb 24;176(9A):V06130350. Ugeskr Laeger. 2014. PMID: 25350408 Review. Danish.
Cited by
-
New Targeted Treatments for Fragile X Syndrome.Curr Pediatr Rev. 2019;15(4):251-258. doi: 10.2174/1573396315666190625110748. Curr Pediatr Rev. 2019. PMID: 31241016 Free PMC article. Review.
-
GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome.eNeuro. 2017 Mar 1;4(1):ENEURO.0380-16.2017. doi: 10.1523/ENEURO.0380-16.2017. eCollection 2017 Jan-Feb. eNeuro. 2017. PMID: 28451631 Free PMC article.
-
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders.Schizophr Res Treatment. 2016;2016:6378137. doi: 10.1155/2016/6378137. Epub 2016 Mar 17. Schizophr Res Treatment. 2016. PMID: 27073698 Free PMC article. Review.
-
Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012.Bioorg Med Chem Lett. 2012 Jan 15;22(2):1044-8. doi: 10.1016/j.bmcl.2011.11.110. Epub 2011 Dec 6. Bioorg Med Chem Lett. 2012. PMID: 22197142 Free PMC article.
-
Understanding the Molecular Basis of Fragile X Syndrome Using Differentiated Mesenchymal Stem Cells.Iran J Child Neurol. 2022 Winter;16(1):85-95. doi: 10.22037/ijcn.v15i4.22070. Epub 2022 Jan 1. Iran J Child Neurol. 2022. PMID: 35222660 Free PMC article.
References
-
- Sutherland G. R. (1977) Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science 197, 265–266. - PubMed
-
- Verkerk A. J.; Pieretti M.; Sutcliffe J. S.; Fu Y. H.; Kuhl D. P.; Pizzuti A.; Reiner O.; Richards S.; Victoria M. F.; Zhang F. P. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905–914. - PubMed
-
- Symons F. J.; Byiers B. J.; Raspa M.; Bishop E.; Bailey D. B. (2010) Self-injurious behavior and fragile X syndrome: findings from the national fragile X survey. Am. J. Intellect. Dev. Disability 115, 473–481. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous